Skip to main content
Premium Trial:

Request an Annual Quote

Metabolomics Australia Buys $2.5M of Agilent's Research Instruments

NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has sold roughly $2.5 million in mass spectrometry, gas and liquid chromatography, and capillary electrophesis instruments and software to Metabolomics Australia, which will use the tools to provide services to researchers in Australia.
 
Metabolomics Australia is a National Collaborative Research Infrastructure Strategy Centre that is managed by Bioplatforms Australia, and it is focused on providing services to researchers in medical, agricultural, and environmental applications of metabolomics.
 
The center includes collaborations with the University of Melbourne, the University of Western Australia, Murdoch University, the Australian Wine Research Institute, and the University of Queensland.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.